Insiders · Profile

Mokari Atabak

Chief Financial Officer at CORCEPT THERAPEUTICS. Filing since 1 Jun 2026. CIK 0001678419

Company
Date
Role
Action
Shares
Amount
Of holding
30 Jul 2026
Chief Financial Officer
Sold on a plan
80,000
$9.18M
83.2%
15 Jul 2026
Chief Financial Officer
Sold on a plan
40,000
$3.51M
71.3%
15 Jun 2026
Chief Financial Officer
Sold on a plan
40,000
$3.25M
71.3%
1 Jun 2026
Chief Financial Officer
Sold on a plan
40,000
$2.80M
72.4%
4 decisions on file.